ARK Investment Management LLC 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-10 3:12 pm Sale |
2021-02-28 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ARK Investment Management LLC | 858,960 13.940% |
-45,172 (-5.00%) |
Filing |
| 2021-02-16 4:33 pm Sale |
2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ARK Investment Management LLC | 904,132 19.740% |
-217,119 (-19.36%) |
Filing |
| 2020-10-09 2:16 pm Purchase |
2020-06-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ARK Investment Management LLC | 1,121,251 24.500% |
613,470 (+120.81%) |
Filing |